Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone/Formoterol Single Inhaler in Moderate to Severe Asthma
NCT00476268Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Feb 2004; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00476268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476268.